Snowball logo
logo
NYKD

Nykode Therapeutics ASA

NOK 3.435+NOK 0.055Β  (1.63%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
33.967.16812.98.679-0.198
COGS
------
Gross Profit
33.967.16812.98.679--
Operating Expenses & Income
Operating Income
(10.78)(53.16)(58.08)(48.33)(28.59)(85.69)
Total Operating Expenses
44.7460.3270.9857.0128.5980.77
R&D Expenses
16.326.7729.3614.7313.410
Selling General & Admin Expenses
9.2838.8926.2784.34513.559.844
Earnings from Continuing Operations
Interest Expense
(0.13)(0.241)(0.224)(0.188)(0.125)(0.115)
Interest Income
0.3422.31142.81813.162.941
Income Tax Expense
(1.704)(8.24)(8.932)(6.692)-(3.355)
Net Income
Net Income
(9.414)(42.74)(35.15)(38.82)(12.24)(48.21)
Supplemental
EBIT
(10.99)(50.74)(43.86)(45.33)--
EBITDA
(10.25)(48.93)(41.74)(43.07)--
In millions of NOK, except % and values per 1 share